[ESPR] QoQ Quarter Result on 30-Sep-2017 [#Q3]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
07-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- -4.34%
YoY- -159.85%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -45,730 -46,130 -37,891 -45,219 -43,337 -40,541 -28,956 35.72%
Tax 0 0 807 606 433 482 423 -
NP -45,730 -46,130 -37,891 -45,219 -43,337 -40,541 -28,956 35.72%
Tax Rate - - - - - - - -
Total Cost 45,730 46,130 37,891 45,219 43,337 40,541 28,956 35.72%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
EPS -1.71 -1.73 -1.44 -1.86 -1.92 -1.80 -1.28 21.36%
EPS Diluted -1.71 -1.73 -1.44 -1.86 -1.92 -1.80 -1.28 21.36%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.